PTGS2 and metabolic dysfunction-associated steatotic liver disease: In the present study, LPSF/GQ-02 effectively reduced the expression of COX-2 in an animal model of NAFLD, strengthening the hypothesis that this thiazolidine derivative decreases inflammation in the hepatic tissue.